Tuya Inc. Sponsored ADR (TUYA) Is Up 0.99% in One Week: What You Should Know
https://www.zacks.com/stock/news/2202773/tuya-inc-sponsored-adr-tuya-is-up-0-99-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2202773
Dec 27, 2023 - Does Tuya Inc. Sponsored ADR (TUYA) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
5 Leveraged ETFs That Are Up More Than 50% in December
https://www.zacks.com/stock/news/2202646/5-leveraged-etfs-that-are-up-more-than-50-in-december?cid=CS-ZC-FT-etf_news_and_commentary-2202646
Dec 27, 2023 - The demand for leveraged ETFs have increased as investors seek to register big gains in a short span.
0
TopBuild (BLD) Is Up 0.40% in One Week: What You Should Know
https://www.zacks.com/stock/news/2203275/topbuild-bld-is-up-0-40-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2203275
Dec 28, 2023 - Does TopBuild (BLD) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Pool Corp (POOL) Up 34% This Year: What Awaits in 2024?
https://www.zacks.com/stock/news/2203326/pool-corp-pool-up-34-this-year-what-awaits-in-2024?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2203326
Dec 28, 2023 - Strong maintenance and repair demand is likely to benefit Pool Corp (POOL) amid softened new pool construction activities.
0
Santa Claus Rally Losing Steam; Jobless Claims Up a Bit
https://www.zacks.com/stock/news/2203200/santa-claus-rally-losing-steam-jobless-claims-up-a-bit?cid=CS-ZC-FT-ahead_of_wall_street-2203200
Dec 28, 2023 - The economy has done better than expected through 2023 -- how long can this continue?
0
Marriott (MAR) Up 51% YTD: Will the Bull Run Continue in 2024?
https://www.zacks.com/stock/news/2203595/marriott-mar-up-51-ytd-will-the-bull-run-continue-in-2024?cid=CS-ZC-FT-analyst_blog|rank_focused-2203595
Dec 29, 2023 - Marriott (MAR) benefits from strong leisure demand and positive global booking trends.
0
Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know
https://www.zacks.com/stock/news/2204183/amphastar-pharmaceuticals-amph-is-up-1-53-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2204183
Jan 01, 2024 - Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
HSBC Wraps Up Sale of France-Based Retail Banking Business
https://www.zacks.com/stock/news/2204418/hsbc-wraps-up-sale-of-france-based-retail-banking-business?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2204418
Jan 02, 2024 - HSBC completes the divestiture of its French retail banking business. The company will continue to provide wealth and private banking businesses in the country.
0
Limbach (LMB) Is Up 1.84% in One Week: What You Should Know
https://www.zacks.com/stock/news/2205162/limbach-lmb-is-up-1-84-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2205162
Jan 03, 2024 - Does Limbach (LMB) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
https://www.zacks.com/stock/news/2204966/longboard-pharma-lbph-up-on-upbeat-data-from-epilepsy-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2204966
Jan 03, 2024 - Longboard Pharma (LBPH) skyrockets 316% on positive data from phase Ib/IIa study of bexicaserin for the treatment of seizures associated with a broad range of epilepsy indications.
0